Loading organizations...
Nord France Amorçage operates as a regional co-investment fund, providing equity financing to innovative, high-potential companies within the Hauts-de-France region. The entity partners with other investors to support the growth of young enterprises, focusing on the seed and early-development phases. Their intervention is designed to inject capital and foster the expansion of regional businesses that demonstrate strong innovation capabilities and potential for creating economic value.
The fund was established in 2013, created and fully owned by the Hauts-de-France Region. The initial insight was to address the critical need for fostering local innovation and job creation through dedicated early-stage capital. The management of the fund is delegated to Groupe Siparex, an independent investment firm, with figures like Thierry Dujardin serving as its President, overseeing its strategic direction and operational execution.
Nord France Amorçage serves startups and emerging companies situated in the Hauts-de-France territory that are navigating their initial phases of development and require fundraising for growth. The fund's overarching vision is to cultivate a dynamic ecosystem by championing innovative regional economic actors, thereby driving territorial development and stimulating sustainable job creation across the region.
Nord France Amorçage has 1 tracked investment across 1 company. The latest tracked deal is $49.9M Series B in Lattice Medical in October 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 24, 2025 | Lattice Medical | $49.9M Series B | Bpifrance, SPI | Blast.club, Captech Sant, EIC Fund, FIRA Nord EST, FundersClub, Sprim Global Investments, Tidjee |